Schwabe acquires majority stake in Braineffect
2025-03-17
The Schwabe Group has increased its shares in Braineffect, acquired in 2020, and now holds the majority in the Berlin-based company that develops nutritional supplements and so-called "functional foods."
“With Braineffect, we bring on board a brand brimming with innovation and perfectly aligned with our purpose to help people live healthier lives,” says Olaf Schwabe, CEO of the Schwabe Group.
This partnership goes beyond a mere acquisition: it’s about combining the best of both worlds to tap into new audiences and redefine what it means to be healthy in a digital age. Stay tuned—there’s more to come!
Founder and CEO Fabian Foelsch remains on board, continuing to guide Braineffect’s future success.
Are you a journalist with questions about the acquisition? Please contact Uta Wanner, Director of Corporate Communications at Schwabe Group, at uta.wanner@schwabe-group.cm